SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Maeve P. Crowely, Shane Quinn, Eoin Coleman, Joseph A. Eustace, Oonagh M. Gilligan, Susan I. O. Shea, Differing coagulation profiles of patients with monoclonal gammopathy of undetermined significance and multiple myeloma, Journal of Thrombosis and Thrombolysis, 2015, 39, 2, 245

    CrossRef

  2. 2
    Michael J. Kovacs, Gwynivere A. Davies, Judy-Anne W. Chapman, Nizar Bahlis, Michael Voralia, Jean Roy, C. Tom Kouroukis, Christine Chen, Andrew Belch, Donna Reece, Liting Zhu, Ralph M. Meyer, Lois Shepherd, Keith A. Stewart, Thalidomide-prednisone maintenance following autologous stem cell transplant for Multiple Myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10, British Journal of Haematology, 2015, 168, 4
  3. 3
    Anetta Undas, Lidia Zubkiewicz-Usnarska, Grzegorz Helbig, Dariusz Woszczyk, Justyna Kozińska, Anna Dmoszyńska, Maria Podolak-Dawidziak, Kazimierz Kuliczkowski, Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma, European Journal of Clinical Investigation, 2014, 44, 6
  4. 4
    Jacek Treliński, Małgorzata Misiewicz, Marta Robak, Piotr Smolewski, Krzysztof Chojnowski, Assessment of rotation thromboelastometry (ROTEM) parameters in patients with multiple myeloma at diagnosis, Thrombosis Research, 2014, 133, 4, 667

    CrossRef

  5. 5
    Domenico Ribatti, Michele Moschetta, Angelo Vacca, Microenvironment and multiple myeloma spread, Thrombosis Research, 2014, 133, S102

    CrossRef

  6. 6
    Mario Roselli, Patrizia Ferroni, Silvia Riondino, Sabrina Mariotti, Anastasia Laudisi, Matteo Vergati, Francesco Cavaliere, Raffaele Palmirotta, Fiorella Guadagni, Impact of chemotherapy on activated protein C-dependent thrombin generation—Association with VTE occurrence, International Journal of Cancer, 2013, 133, 5
  7. 7
    S. Pandey, S. R. Post, D. V. Alapat, K. J. Smock, G. R. Post, Prolonged prothrombin time correlates with serum monoclonal protein concentration in patients with plasma cell dyscrasia, International Journal of Laboratory Hematology, 2013, 35, 4
  8. 8
    N. Vallianou, V. Lazarou, J. Tzangarakis, R. Barounis, E. Sioula, Pulmonary Embolism as the First Manifestation of Multiple Myeloma, Case Reports in Medicine, 2013, 2013, 1

    CrossRef

  9. 9
    Nur Soyer, Burcin Kececi, Zuhal Eroglu, Serra Kamer, Cagri Ozcelik, Seckin Cagirgan, Murat Tombuloglu, Dundar Sabah, Ayhan Donmez, Acquired activated protein C resistance in sarcoma patients, Blood Coagulation & Fibrinolysis, 2012, 23, 5, 428

    CrossRef

  10. 10
    Patrizia Ferroni, Silvia Riondino, Ilaria Portarena, Vincenzo Formica, Francesca La Farina, Francesca Martini, Gioia Massimiani, Raffaele Palmirotta, Fiorella Guadagni, Mario Roselli, Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer, International Journal of Colorectal Disease, 2012, 27, 12, 1561

    CrossRef

  11. 11
    Patrizia Ferroni, Francesca Martini, Ilaria Portarena, Italia Grenga, Silvia Riondino, Francesca La Farina, Anastasia Laudisi, Fiorella Guadagni, Mario Roselli, Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients—a pilot study, Supportive Care in Cancer, 2012, 20, 11, 2713

    CrossRef

  12. 12
    F. Elice, F. Rodeghiero, Hematologic malignancies and thrombosis, Thrombosis Research, 2012, 129, 3, 360

    CrossRef

  13. 13
    Marta Robak, Jacek Treliński, Krzysztof Chojnowski, Hemostatic changes after 1 month of thalidomide and dexamethasone therapy in patients with multiple myeloma, Medical Oncology, 2012, 29, 5, 3574

    CrossRef

  14. 14
    Eileen M Boyle, Guillemette Fouquet, Salomon Manier, Jordan Gauthier, Marie Pierre Noel, Claire Borie, Thierry Facon, Ismail Elalamy, Xavier Leleu, Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosis, Expert Review of Hematology, 2012, 5, 6, 619

    CrossRef

  15. 15
    E. Chalayer, K. Augeul-Meunier, B. Tardy-Poncet, P. Cathebras, D. Guyotat, B. Tardy, Myélome multiple de novo : faut-il proposer une prophylaxie antithrombotique ?, La Revue de Médecine Interne, 2012, 33, 12, 693

    CrossRef

  16. 16
    Frank W.G. Leebeek, Marieke J.H.A. Kruip, Pieter Sonneveld, Risk and management of thrombosis in multiple myeloma, Thrombosis Research, 2012, 129, S88

    CrossRef

  17. 17
    Maurizio Zangari, Tamara Berno, Fenghuang Zhan, Kenneth M. Boucher, Guido Tricot, Louis Fink, Activated protein C resistance as measured by residual factor V after Russellʼs Viper Venom and activated protein C treatment analyzed as a continuous variable in multiple myeloma and normal controls, Blood Coagulation & Fibrinolysis, 2011, 22, 5, 420

    CrossRef

  18. 18
    Sigurdur Yngvi Kristinsson, Magnus Björkholm, Sam Schulman, Ola Landgren, Hypercoagulability in Multiple Myeloma and Its Precursor State, Monoclonal Gammopathy of Undetermined Significance, Seminars in Hematology, 2011, 48, 1, 46

    CrossRef

  19. 19
    Georg Aue, Jay Nelson Lozier, Xin Tian, Ann M. Cullinane, Susan Soto, Leigh Samsel, Philip McCoy, Adrian Wiestner, Inflammation, TNFα and endothelial dysfunction link lenalidomide to venous thrombosis in chronic lymphocytic leukemia, American Journal of Hematology, 2011, 86, 10
  20. 20
    Ana Pilar González Rodríguez, Management of the adverse effects of lenalidomide in multiple myeloma, Advances in Therapy, 2011, 28, S1, 1

    CrossRef

  21. 21
    M. CARRIER, G. LE GAL, J. TAY, C. WU, A. Y. LEE, Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis, Journal of Thrombosis and Haemostasis, 2011, 9, 4
  22. 22
    Ozlem S Balcik, Murat Albayrak, Mehtap E Uyar, Simten Dagdas, Osman Yokus, Funda Ceran, Handan Cipil, Ali Kosar, Gulsum Ozet, Serum thrombin activatable fibrinolysis inhibitor levels in patients with newly diagnosed multiple myeloma, Blood Coagulation & Fibrinolysis, 2011, 22, 4, 260

    CrossRef

  23. 23
    E. J. Libourel, P. Sonneveld, B. van der Holt, M. P. M. de Maat, F. W. G. Leebeek, High incidence of arterial thrombosis in young patients treated for multiple myeloma: results of a prospective cohort study, Blood, 2010, 116, 1, 22

    CrossRef

  24. 24
    Michela Cini, Elena Zamagni, Lelia Valdré, Gualtiero Palareti, Francesca Patriarca, Paola Tacchetti, Cristina Legnani, Lucio Catalano, Luciano Masini, Patrizia Tosi, Alessandro Gozzetti, Michele Cavo, Thalidomide–dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin, European Journal of Haematology, 2010, 84, 6
  25. 25
    S. Y. Kristinsson, Thrombosis in Multiple Myeloma, Hematology, 2010, 2010, 1, 437

    CrossRef

  26. 26
    Noppacharn Uaprasert, Peter M. Voorhees, Nigel Mackman, Nigel S. Key, Venous thromboembolism in multiple myeloma: Current perspectives in pathogenesis, European Journal of Cancer, 2010, 46, 10, 1790

    CrossRef

  27. 27
    Ted Wun, Richard H. White, Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma, Thrombosis Research, 2010, 125, S96

    CrossRef

  28. 28
    Khaled M. Musallam, Fadi S. Dahdaleh, Ali I. Shamseddine, Ali T. Taher, Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy, Thrombosis Research, 2009, 123, 5, 679

    CrossRef

  29. 29
    Charles Eby, Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasias, British Journal of Haematology, 2009, 145, 2
  30. 30
    Francesca Elice, Francesco Rodeghiero, Anna Falanga, Frederick R. Rickles, Thrombosis associated with angiogenesis inhibitors, Best Practice & Research Clinical Haematology, 2009, 22, 1, 115

    CrossRef

  31. 31
    Edward N. Libby, Agnes Y. Lee, New Therapeutic Agents in Thrombosis and Thrombolysis, 2009,

    CrossRef

  32. 32
    Sagar Lonial, Paul G Richardson, Jesús San Miguel, Pieter Sonneveld, Michael W Schuster, Joan Bladé, Jamie Cavenagh, S. Vincent Rajkumar, Andrzej J Jakubowiak, Dixie-Lee Esseltine, Kenneth C Anderson, Jean-Luc Harousseau, Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma, British Journal of Haematology, 2008, 143, 2
  33. 33
    S. Y. Kristinsson, T. R. Fears, G. Gridley, I. Turesson, U.-H. Mellqvist, M. Bjorkholm, O. Landgren, Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma, Blood, 2008, 112, 9, 3582

    CrossRef

  34. 34
    Attaya Suvannasankha, Rafat Abonour, Oscar W. Cummings, Suthat Liangpunsakul, Gastrointestinal Plasmacytoma Presenting as Gastrointestinal Bleeding, Clinical Lymphoma and Myeloma, 2008, 8, 5, 309

    CrossRef

  35. 35
    D. C. Johnson, S. Corthals, C. Ramos, A. Hoering, K. Cocks, N. J. Dickens, J. Haessler, H. Goldschmidt, J. A. Child, S. E. Bell, G. Jackson, D. Baris, S. V. Rajkumar, F. E. Davies, B. G. M. Durie, J. Crowley, P. Sonneveld, B. Van Ness, G. J. Morgan, Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping, Blood, 2008, 112, 13, 4924

    CrossRef

  36. 36
    Francesca Elice, Jack Jacoub, Frederick R. Rickles, Anna Falanga, Francesco Rodeghiero, Hemostatic complications of angiogenesis inhibitors in cancer patients, American Journal of Hematology, 2008, 83, 11
  37. 37
    Anna D. Petropoulou, Grigoris T. Gerotziafas, Meyer M. Samama, Mohamed Hatmi, Francine Rendu, Ismail Elalamy, In vitro study of the hypercoagulable state in multiple myeloma patients treated or not with thalidomide, Thrombosis Research, 2008, 121, 4, 493

    CrossRef

  38. 38
    H. F. S. NEGAARD, P. O. IVERSEN, B. ØSTENSTAD, M. C. MOWINCKEL, P. M. SANDSET, Increased acquired activated protein C resistance in unselected patients with hematological malignancies, Journal of Thrombosis and Haemostasis, 2008, 6, 9
  39. 39
    Adriana M.W. van Marion, Johannes J.A. Auwerda, Ton Lisman, Pieter Sonneveld, M.P.M. de Maat, Henk M. Lokhorst, Frank W.G. Leebeek, Prospective evaluation of coagulopathy in multiple myeloma patients before, during and after various chemotherapeutic regimens, Leukemia Research, 2008, 32, 7, 1078

    CrossRef

  40. 40
    Dorothy M. Adcock, Louis M. Fink, Richard A. Marlar, Federica Cavallo, Maurizio Zangari, The Hemostatic System and Malignancy, Clinical Lymphoma and Myeloma, 2008, 8, 4, 230

    CrossRef

  41. 41
    M. Marchetti, E. Castoldi, H. M. H. Spronk, R. van Oerle, D. Balducci, T. Barbui, J. Rosing, H. ten Cate, A. Falanga, Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera, Blood, 2008, 112, 10, 4061

    CrossRef

  42. 42
    Smitha Patiyil Menon, S. Vincent Rajkumar, Martha Lacy, Patrizia Falco, Antonio Palumbo, Thromboembolic events with lenalidomide-based therapy for multiple myeloma, Cancer, 2008, 112, 7
  43. 43
    C. S. Eby, Bleeding and Thrombosis Risks in Plasma Cell Dyscrasias, Hematology, 2007, 2007, 1, 158

    CrossRef

  44. 44
    Elena Zamagni, Lelia Valdrè, Gualtiero Palareti, Michele Cavo, Prevention of VTE in multiple myeloma patients, Thrombosis Research, 2007, 120, S133

    CrossRef

  45. 45
    Johannes J.A. Auwerda, Pieter Sonneveld, Moniek P.M. de Maat, Frank W.G. Leebeek, Prothrombotic Coagulation Abnormalities in Patients with Paraprotein-Producing B-Cell Disorders, Clinical Lymphoma and Myeloma, 2007, 7, 7, 462

    CrossRef

  46. 46
    Efstathios Kastritis, Meletios A. Dimopoulos, Thalidomide in the treatment of multiple myeloma, Best Practice & Research Clinical Haematology, 2007, 20, 4, 681

    CrossRef

  47. 47
    Hervé Decousus, Nathalie Moulin, Sara Quenet, Vincent Bost, Karine Rivron-Guillot, Silvy Laporte, Patrick Mismetti, Thrombophilia and risk of venous thrombosis in patients with cancer, Thrombosis Research, 2007, 120, S51

    CrossRef

  48. 48
    Hau C. Kwaan, Brian Vicuna, Thrombosis and bleeding in cancer patients, Oncology Reviews, 2007, 1, 1, 14

    CrossRef

  49. 49
    Maurizio Zangari, Francesca Elice, Louis Fink, Guido Tricot, Thrombosis in multiple myeloma, Expert Review of Anticancer Therapy, 2007, 7, 3, 307

    CrossRef

  50. 50
    Anna Falanga, Marina Marchetti, Cancer-Associated Thrombosis, 2007,

    CrossRef